Fresenius SE & Co KGaA (FSNUY)
8.78
+0.16
(+1.86%)
USD |
OTCM |
Nov 15, 16:00
Fresenius Enterprise Value: 30.35B for Nov. 15, 2024
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| November 15, 2024 | 30.35B |
| November 14, 2024 | 29.99B |
| November 13, 2024 | 30.17B |
| November 12, 2024 | 30.49B |
| November 11, 2024 | 30.78B |
| November 08, 2024 | 31.17B |
| November 07, 2024 | 31.30B |
| November 06, 2024 | 31.67B |
| November 05, 2024 | 31.50B |
| November 04, 2024 | 31.08B |
| November 01, 2024 | 31.41B |
| October 31, 2024 | 31.23B |
| October 30, 2024 | 31.12B |
| October 29, 2024 | 31.46B |
| October 28, 2024 | 31.68B |
| October 25, 2024 | 31.09B |
| October 24, 2024 | 31.14B |
| October 23, 2024 | 30.81B |
| October 22, 2024 | 30.99B |
| October 21, 2024 | 31.10B |
| October 18, 2024 | 31.03B |
| October 17, 2024 | 30.93B |
| October 16, 2024 | 31.24B |
| October 15, 2024 | 31.26B |
| October 14, 2024 | 31.30B |
| Date | Value |
|---|---|
| October 11, 2024 | 31.26B |
| October 10, 2024 | 31.35B |
| October 09, 2024 | 31.71B |
| October 08, 2024 | 31.55B |
| October 07, 2024 | 31.35B |
| October 04, 2024 | 31.71B |
| October 03, 2024 | 31.73B |
| October 02, 2024 | 31.94B |
| October 01, 2024 | 32.08B |
| September 30, 2024 | 32.16B |
| September 27, 2024 | 31.83B |
| September 26, 2024 | 31.92B |
| September 25, 2024 | 31.52B |
| September 24, 2024 | 31.61B |
| September 23, 2024 | 31.50B |
| September 20, 2024 | 31.59B |
| September 19, 2024 | 32.01B |
| September 18, 2024 | 32.17B |
| September 17, 2024 | 32.20B |
| September 16, 2024 | 32.15B |
| September 13, 2024 | 32.26B |
| September 12, 2024 | 31.74B |
| September 11, 2024 | 31.86B |
| September 10, 2024 | 31.77B |
| September 09, 2024 | 31.67B |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
27.55B
Minimum
Jun 30 2024
64.77B
Maximum
May 24 2021
49.52B
Average
51.40B
Median
Aug 29 2023
Enterprise Value Benchmarks
| Affimed NV | 26.82M |
| InflaRx NV | 50.17M |
| BioNTech SE | 5.516B |
| Immatics NV | 273.08M |
| CureVac NV | 348.68M |
Enterprise Value Related Metrics
| Net Income (Quarterly) | 358.54M |
| Revenue (Quarterly) | 5.902B |
| Total Expenses (Quarterly) | 5.360B |
| EPS Diluted (Quarterly) | 0.1595 |
| Gross Profit Margin (Quarterly) | 25.40% |
| Profit Margin (Quarterly) | 6.08% |
| Earnings Yield | -2.03% |
| Operating Earnings Yield | 7.64% |
| Normalized Earnings Yield | 2.574 |